Contact this trialFirst, we need to learn more about you.
Chemotherapy
Pembrolizumab for Esophageal and Gastric Cancers
Recruiting1 awardPhase 2
Durham, North Carolina
This trial is testing a combination of neoadjuvant pembrolizumab (a cancer treatment) with chemoradiotherapy and adjuvant pembrolizumab (also a cancer treatment) to see if it is effective and safe in patients with locally advanced esophageal and gastric cancers.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.